MARKET

IRWD

IRWD

Ironwood
NASDAQ
4.300
+0.250
+6.17%
After Hours: 4.310 +0.01 +0.23% 19:34 08/11 EDT
OPEN
4.080
PREV CLOSE
4.050
HIGH
4.315
LOW
4.060
VOLUME
1.93M
TURNOVER
--
52 WEEK HIGH
5.78
52 WEEK LOW
0.8100
MARKET CAP
710.53M
P/E (TTM)
5.67
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IRWD last week (0803-0807)?
Weekly Report · 1d ago
Ironwood Pharmaceuticals (IRWD) Stock Faces A Sentiment Check After Raised Guidance
Simply Wall St · 4d ago
Ironwood Pharmaceuticals’ Earnings Call Highlights LINZESS Surge
TipRanks · 4d ago
Ironwood Pharmaceuticals Q2 Earnings Call Highlights
NASDAQ · 5d ago
*Ironwood Pharmaceuticals Raises FY26 View To Rev $460M-$485M >IRWD
Dow Jones · 5d ago
Ironwood Pharmaceuticals reports mixed Q2 results; raises FY26 outlook
Seeking Alpha · 5d ago
*Ironwood Pharmaceuticals Raises 2026 Full-Yr Fincl Guidance
Dow Jones · 5d ago
*Ironwood Pharmaceuticals 2Q Adj EPS 31c >IRWD
Dow Jones · 5d ago
More
About IRWD
Ironwood Pharmaceuticals, Inc. is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI), and rare diseases. It is focused on the development and commercialization of GI product opportunities in areas of significant unmet need. LINZESS (linaclotide), its commercial product, is indicated for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C), or chronic idiopathic constipation (CIC), and for pediatric patients ages 6-17 years-old suffering from functional constipation (FC). Linaclotide is available under the trademarked name CONSTELLA to adult men and women suffering from IBS-C or CIC and pediatric patients. The Company is also engaged in advancing apraglutide, a synthetic long-acting peptide analog of glucagon-like peptide-2 (GLP-2), for short bowel syndrome (SBS), patients who are dependent on parenteral support.

Webull offers Ironwood Pharmaceuticals, Inc. stock information, including NASDAQ: IRWD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRWD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IRWD stock methods without spending real money on the virtual paper trading platform.